Merck Follistim AQ by Year

Name: Merck Follistim AQ by Year (MRK)
Creator: Merck

Follistim AQ (follitropin beta, legacy pre-Organon spin-off) — Worldwide sales ($M) ($M)

Quarterly Annual

Merck Follistim AQ: $193M in FY2020, down 19.9% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2020

193

Period ended Dec 31, 2020

Change on a year earlier

-19.9%

241 in FY2019

History

5 years

Since FY2016

Sources

Documents cited below

Where the FY2020 figure comes from

“|| Follistim AQ | 52 | 41 | 44 | 50 | 57 | 193 | 25 | 21”

Source: Form 8-K (tm2114316d1_ex99-1.htm, filed 2021-04-29) ↗

Reported in Form 10-Q / 10-K Segment & Product Sales Footnote & Form 8-K Table 3 / 3a / 3b.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Follistim AQ (follitropin beta, legacy pre-Organon spin-off) — Worldwide sales ($M) ($M)	Year on year	Source
FY2020	Dec 31, 2020	193	-19.9%	Form 8-K (tm2114316d1_ex99-1.htm, filed 2021-04-29) ↗
FY2019	Dec 31, 2019	241	-10.1%	Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗
FY2018	Dec 31, 2018	268	-10.1%	Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗
FY2017	Dec 31, 2017	298	-16.1%	Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗
FY2016	Dec 31, 2016	355	–	Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗

Breakdown

What makes up follistim AQ

Cite this data

StockData. (2026). Merck Follistim AQ ($M), annual FY2016–FY2020 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-follistim-aq

See every metric in the Merck KPI table. Data updated Oct 26, 2026.